FGA
TTOO

Fortis Group Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Fortis Group Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$19K Buy
+3
New +$22.2K ﹤0.01% 250

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fortis Group Advisors's TTOO Position: Q3 2020 in Review

Fortis Group Advisors opened a new position in T2 Biosystems, Inc (TTOO) in Q3 2020: 3 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #250 among its holdings.

53 funds tracked by Wall St. Rank hold TTOO as of Q3 2020.

  • Fortis Group Advisors held 3 shares of T2 Biosystems, Inc worth $19K as of Q3 2020.
  • T2 Biosystems, Inc was a new Fortis Group Advisors position in Q3 2020.
  • T2 Biosystems, Inc made up ﹤0.01% of Fortis Group Advisors's portfolio in Q3 2020, its #250 holding.
  • 53 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2020.

Based on Fortis Group Advisors's 13F filing for Q3 2020, filed 17 Nov 2020.